Safety and Efficacy Study of Healos as a Bone Replacement to Treat Degenerative Disc Disease
Degenerative Disc Disease
About this trial
This is an interventional treatment trial for Degenerative Disc Disease focused on measuring One or Two Level Degenerative Disc Disease
Eligibility Criteria
Inclusion Criteria: Persistent back and/or leg pain refractory to 6 months of non-surgical therapy Male or female 18 to 70 years of age (inclusive) Objective evidence of significant disc degeneration at one or two adjacent lumbar level(s) from L2/L3 to L5/S1 Exclusion Criteria: Significant disc degeneration at more than two adjacent levels Greater than Grade II spondylolisthesis Prior fusion surgery of the lumbar spine (prior discectomies and intradiscal electrothermal therapy [IDET] are allowed) Insulin-dependent diabetes mellitus Pregnant or lactating, or wishes to become pregnant within the 24 month duration of the study
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
1
2